Curaleaf Holdings (CURLF) Raw Materials (2019 - 2022)
Curaleaf Holdings (CURLF) posted quarterly Raw Materials of $60.3 million for Q4 2022, down 31.16% year-on-year from $87.6 million in Q4 2021, and down 31.16% on a QoQ basis from $87.6 million in Q4 2021.
Curaleaf Holdings (CURLF) Raw Materials (2019 - 2022) Analysis & Trends
Curaleaf Holdings (CURLF) has reported Raw Materials for 4 consecutive years, with $60.3 million the latest figure, recorded in Q4 2022.
- Quarterly Raw Materials fell 31.16% year-over-year to $60.3 million in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $60.3 million (down 31.16% YoY) and the FY2021 annual result came in at $87.6 million, up 205.23% from the prior year.
- Raw Materials declined to $60.3 million in Q4 2022 per CURLF's latest filing, from $87.6 million in the prior quarter.
- Over the last five years, Raw Materials for CURLF reached as high as $87.6 million in Q4 2021 and fell as low as $8.7 million in Q4 2019.
- A 4-year average of $46.3 million and a median of $44.5 million in 2020 frame the typical range for Raw Materials.
- Annual changes were most pronounced in 2020 — Raw Materials surged 231.06% — and 2022, when it slumped 31.16%.
- Year by year, Raw Materials stood at $8.7 million in 2019, then jumped by 231.06% to $28.7 million in 2020, then jumped by 205.23% to $87.6 million in 2021, then sank by 31.16% to $60.3 million in 2022.
- According to Business Quant data, Raw Materials over the past three periods registered $60.3 million, $87.6 million, and $28.7 million for Q4 2022, Q4 2021, and Q4 2020 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Curaleaf Holdings | 7.13 Bn | 7.13 Bn | 157.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 60.31 Mn |
| Dec 31, 2021 | 87.61 Mn |
| Dec 31, 2020 | 28.70 Mn |
| Dec 31, 2019 | 8.67 Mn |